Related Experiment Video
Updated: Sep 13, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Clinical familial hypercholesterolemia, heart healthy dietary adherence, and cardiovascular risk
Frida Toft-Nielsen1, Frida Emanuelsson2, Børge G Nordestgaard3
1Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen, 2200, Denmark.
Insights
A heart-healthy diet lowers harmful lipids and reduces cardiovascular risk in familial hypercholesterolemia (FH) patients, even when on medication. Emphasizing diet alongside medication is key for managing FH.
Area of Science:
- Cardiology
- Nutritional Science
- Genetics
Background:
- Familial hypercholesterolemia (FH) significantly elevates the risk of premature cardiovascular disease.
- Lifestyle interventions and lipid-lowering medications are crucial for risk reduction in FH patients.
Purpose of the Study:
- To investigate whether adherence to a heart-healthy diet offers additional cardiovascular risk reduction in FH patients, independent of lipid-lowering medication.
Main Methods:
- Utilized Dutch Lipid Clinic Network (DLCN) criteria for FH diagnosis in a large population study.
- Assessed dietary adherence to Danish/international guidelines and measured various lipid/lipoprotein levels and ischemic heart disease (IHD) risk.
Main Results:
- Higher heart-healthy dietary adherence correlated with lower levels of LDL cholesterol, apoB, non-HDL cholesterol, remnant cholesterol, and triglycerides.
- Reduced risk of ischemic heart disease (IHD) was observed with increased dietary adherence, irrespective of FH status or medication use.
Conclusions:
- Adherence to a heart-healthy diet demonstrably lowers atherogenic lipids and reduces IHD risk in FH individuals.
- Dietary adherence is a vital supplementary strategy to lipid-lowering medication for managing FH.
Background And Aims:
Individuals with familial hypercholesterolemia (FH) are at high risk of premature cardiovascular disease. A healthy lifestyle and lipid-lowering medication are essential to reduce this risk. We examined if adherence to a heart healthy diet provides additional risk reduction independent of lipid-lowering medication.
Methods:
The Dutch Lipid Clinic Network (DLCN) criteria was used to diagnose FH (n=559 individuals with probable or definite FH) in the Copenhagen General Population Study(n=106,899) and the Copenhagen City Heart Study(n=7,451). Individuals were categorised by their level of heart healthy dietary adherence to Danish dietary guidelines, corresponding to international guidelines. Concentrations of low-density lipoprotein (LDL) cholesterol, apolipoprotein B (apoB), non-high-density lipoprotein (HDL) cholesterol, remnant cholesterol, triglycerides, and lipoprotein(a) (Lp(a)), and risk of ischaemic heart disease (IHD) were assessed by clinical FH category and level of dietary adherence.
Results:
Women had a higher heart healthy dietary adherence compared to men. Mean concentrations of LDL cholesterol, apoB, non-HDL cholesterol, remnant cholesterol, and triglycerides increased stepwise by lower dietary adherence category, regardless of clinical FH category. Lp(a) concentration did not change by adherence to dietary guidelines. Results were similar in individuals taking lipid-lowering medication. Risk of ischemic heart disease (IHD) was lower in individuals with a higher dietary adherence (ranging from 8 to 57 % lower risk) compared to individuals with a very low dietary adherence regardless of clinical FH category.
Conclusions:
Adherence to a heart healthy diet is associated with lower concentrations of atherogenic lipids and lipoproteins, and lower risk of IHD in individuals with clinical FH, independent of treatment with lipid-lowering medication. Dietary adherence should be emphasised as an important tool in addition to treatment with lipid-lowering medication in individuals with FH.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

